Tom Winnifrith BearCast - Advanced Oncotherapy Special
By Tom Winnifrith | Wednesday 3 June 2015
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
It seems as if some folks think that questioning the share price of Advanced Oncotherapy (AVO) is akin to attacking the fight against cancer. It is not. But in this podcast I just have a few questions
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.